Recalling 73m pills might not affect Ranbaxy's revenues

Published on Fri, Nov 16, 2007 at 09:34 |  Source : Moneycontrol.com

Updated at Fri, Nov 16, 2007 at 12:26  

39740 Investors following Ranbaxy Labs. Share this News with them.
0
0
Share on Tumblr

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

Q: How might the market take the news (Ranbaxy recalls 73 m pills of Gabapentin in US retail market after discovering impurities) on Ranbaxy this morning?

A: CNBC-TV18's stocks editor, Udayan Mukherjee - Not very well, not too badly either, because materially it may not mean too much for Ranbaxy , the size of the drug and what they recalling might not tend the revenues materially. But as a Ranbaxy investor, you would tend to worry a little bit about how the US FDA might look at all these things; remember the big cloud over Ranbaxy a few quarters back or throughout the last few quarters has been their Paonta Sahib facility, what the US FDA is going to do with it.

And now for a large number of drugs have been pulled back because of impurities, maybe Ranbaxy comes a little bit more under the scanner of the US FDA. I would worry on that front on whether Ranbaxy is increasingly getting into a bit of a grey-list for the US FDA.

So that is the worry rather than the more material pullback or the revenue impact of this pullback.                     
 

  

Trending News

Business News

Tags: USFDA, Ranbaxy
Sony to roll-out ICS update next week, Xperia PLAY gets the boot
Reebok execs named in Rs 870 cr fraud denied anticipatory bail "Reebok execs named in Rs 870 cr fraud denied anticipatory bail"

Live Updates: KKR favourites in last-over battle

Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)

The latest earning numbers FIRST on CNBC-TV18
Videos

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 27 2012, 11:52 | Source: CNBC-TV18

Expect to maintain EBIDTA margin ahead: Wockhardt  

May 27 2012, 11:00 | Source: CNBC-TV18

e-commerce market in India: What's in store?  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!